Find Fluorothymidine F-18 manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 18f-flt, Alovudine f-18, 3'-deoxy-3'-(18f)fluorothymidine, (18f)flt, Flt f-18, 287114-80-1
Molecular Formula
C10H13FN2O4
Molecular Weight
243.22  g/mol
InChI Key
UXCAQJAQSWSNPQ-ZIVQXEJRSA-N
FDA UNII
2X1K91UT6N

Fluorothymidine F-18
Fluorothymidine F-18 is a radioconjugate consisting of a thymidine analogue radiolabeled with fluorine F 18, a positron emitting isotope. Phosphorylated by S-phase-specific thymidine kinase 1, 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT) is trapped intracellularly by entering the salvage pathway of DNA synthesis without incorporation into DNA. 18F-FLT serves a marker of tumor cell proliferation for imaging with positron emission tomography (PET); as a marker of proliferation rather than metabolism, it is more specific to tumor tissue than 2-deoxy-2-[18F] fluoro-D-glucose (18F-FDG). This agent is metabolically stable, accumulates in the normal bone marrow and the liver, and does not cross the blood-brain barrier.
1 2D Structure

Fluorothymidine F-18

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[(2R,4S,5R)-4-(18F)fluoranyl-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
2.1.2 InChI
InChI=1S/C10H13FN2O4/c1-5-3-13(10(16)12-9(5)15)8-2-6(11)7(4-14)17-8/h3,6-8,14H,2,4H2,1H3,(H,12,15,16)/t6-,7+,8+/m0/s1/i11-1
2.1.3 InChI Key
UXCAQJAQSWSNPQ-ZIVQXEJRSA-N
2.1.4 Canonical SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)F
2.1.5 Isomeric SMILES
CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)[18F]
2.2 Other Identifiers
2.2.1 UNII
2X1K91UT6N
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (18)flt Cpd

2. (18f)3'-deoxy-3'-fluorothymidine

3. (18f)flt

4. 1-(3'-fluoro-3'-deoxy-beta-d-erythropentofuranosyl)thymine

5. 18f-flt

6. 3'-(f-18)fluoro-3'-deoxythymidine

7. 3'-deoxy-3'-(18f)fluorothymidine

8. 3'-deoxy-3'-fluorothymidine

9. 3'-fluoro-2',3'-dideoxythymidine

10. 3'-fluoro-3'-deoxythymidine

11. 3'-fluorothymidine

12. Alovudine

13. Fddt

2.3.2 Depositor-Supplied Synonyms

1. 18f-flt

2. Alovudine F-18

3. 3'-deoxy-3'-(18f)fluorothymidine

4. (18f)flt

5. Flt F-18

6. 287114-80-1

7. Thymidine, 3'-deoxy-3'-(18f)fluoro-

8. 2x1k91ut6n

9. [18f]flt

10. F-18 Fluorothymidine

11. Unii-2x1k91ut6n

12. 3'-deoxy-3'-18f-fluorothymidine

13. Schembl14461296

14. (18f) Flt

15. (18f)-flt

16. (f-18)flt

17. Dtxsid90182869

18. Db14930

19. Fluorothymidine (18f) [who-dd]

20. Q27255730

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 243.22 g/mol
Molecular Formula C10H13FN2O4
XLogP3-0.3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count2
Exact Mass243.088469 g/mol
Monoisotopic Mass243.088469 g/mol
Topological Polar Surface Area78.9 Ų
Heavy Atom Count17
Formal Charge0
Complexity385
Isotope Atom Count1
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antiviral Agents

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty